$Recursion Pharmaceuticals, In

$Recursion Pharmaceuticals, Inc.(RXRX)$ view order details.@Trade Feed Decoder

RXRX

08-30 04:27

USRecursion Pharmaceuticals, Inc.

Side	Price \| Filled	Realized P&L
Buy Open	4.66 50	-- Closed

Recursion Pharmaceuticals, Inc.

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
08-30
Trade Feed Decoder
**Analysis:** The RXRX trade captures a modest +0.86% gain following a buy at $4.66. Given the stock’s biotech sector exposure, this may reflect a short-term play on volatility or event-driven catalysts (e.g., clinical trial updates). While the profit margin is narrow, it aligns with typical intraday or swing-trading strategies in high-beta stocks. Position sizing discipline would be critical here, as biotech names like RXRX often face binary news-driven swings. The trade’s success hinges on precise entry/exit timing, though the extended timestamp raises questions about context (e.g., pre-news vs. technical bounce). Traders might study this as an example of managing risk in speculative holdings while capitalizing on limited upside.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":472938014589832,"tweetId":"472938014589832","gmtCreate":1756499267326,"gmtModify":1758275076391,"author":{"id":4113358555722592,"idStr":"4113358555722592","authorId":4113358555722592,"authorIdStr":"4113358555722592","name":"CP_93","avatar":"https://community-static.tradeup.com/news/353ac2647ace39ffeed65829dea43de8","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":25,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":22,"starInvestorOrderShareNum":215,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":14.01,"showRor":true,"winRationPercentage":61.434978,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Recursion Pharmaceuticals, Inc.(RXRX)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":66,"commentSize":1,"repostSize":39,"favoriteSize":0,"link":"https://ttm.financial/post/472938014589832","repostId":0,"isVote":1,"tweetType":1,"viewCount":2619,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["RXRX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4113358555722592","orderId":"40316768944524288","kind":"TRADE","symbol":"RXRX","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/RXRX","symbolName":"Recursion Pharmaceuticals, Inc.","market":"US","action":"BUY","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Recursion Pharmaceuticals, Inc.","orderType":"LMT","filledQuantityFinal":50,"avgFillPrice":4.66,"createTime":1756499227,"filledQuantity":"50","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Recursion Pharmaceuticals, Inc.","contractExtraDescription":"RXRX","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":0.0594},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":472964092764424,"commentId":"472964092764424","gmtCreate":1756505440970,"gmtModify":1756505445682,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":472938014589832,"objectIdStr":"472938014589832","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"**Analysis:** The RXRX trade captures a modest +0.86% gain following a buy at $4.66. Given the stock’s biotech sector exposure, this may reflect a short-term play on volatility or event-driven catalysts (e.g., clinical trial updates). While the profit margin is narrow, it aligns with typical intraday or swing-trading strategies in high-beta stocks. Position sizing discipline would be critical here, as biotech names like RXRX often face binary news-driven swings. The trade’s success hinges on precise entry/exit timing, though the extended timestamp raises questions about context (e.g., pre-news vs. technical bounce). Traders might study this as an example of managing risk in speculative holdings while capitalizing on limited upside.","text":"**Analysis:** The RXRX trade captures a modest +0.86% gain following a buy at $4.66. Given the stock’s biotech sector exposure, this may reflect a short-term play on volatility or event-driven catalysts (e.g., clinical trial updates). While the profit margin is narrow, it aligns with typical intraday or swing-trading strategies in high-beta stocks. Position sizing discipline would be critical here, as biotech names like RXRX often face binary news-driven swings. The trade’s success hinges on precise entry/exit timing, though the extended timestamp raises questions about context (e.g., pre-news vs. technical bounce). Traders might study this as an example of managing risk in speculative holdings while capitalizing on limited upside.","html":"**Analysis:** The RXRX trade captures a modest +0.86% gain following a buy at $4.66. Given the stock’s biotech sector exposure, this may reflect a short-term play on volatility or event-driven catalysts (e.g., clinical trial updates). While the profit margin is narrow, it aligns with typical intraday or swing-trading strategies in high-beta stocks. Position sizing discipline would be critical here, as biotech names like RXRX often face binary news-driven swings. The trade’s success hinges on precise entry/exit timing, though the extended timestamp raises questions about context (e.g., pre-news vs. technical bounce). Traders might study this as an example of managing risk in speculative holdings while capitalizing on limited upside.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/472938014589832"}